, Tracking Stock Market Picks
Enter Symbol:
Savient Pharmaceuticals Inc (SVNTQ) [hlAlert]

up 636,742.10 %

Savient Pharmaceuticals Inc (SVNT) downgraded to Underperform with price target $5 by Jefferies & Co

Posted on: Tuesday,  Aug 4, 2009  8:25 AM ET by Jefferies & Co

Jefferies & Co rated Underperform Savient Pharmaceuticals Inc (OTCBB: SVNTQ) on 08/04/2009, when the stock price was $12.10.
Since then, Savient Pharmaceuticals Inc has lost 99.98% as of 05/30/2014's recent price of $0.00.
If you would have followed this Jefferies & Co's recommendation on SVNTQ, you would have gained 636742% of your investment in 1760 days.

Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing and marketing pharmaceutical products that target unmet medical needs in both niche and specialty markets. During the year ended December 31, 2008, the Company developed KRYSTEXXA (pegloticase), a therapy for patients with treatment-failure gout (TFG) to control hyperuricemia and to manage the signs and symptoms of gout, including the improvement of tophi, improvement in chronic pain, improved physical functioning and decreased frequency of flares. The Company sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The Company distributes the branded version of oxandrolone in the United States under the name Oxandrin and its authorized generic version of oxandrolone through an agreement with Watson Pharma, Inc. (Watson).

Our focus on growing and mid-sized companies enables us to identify unique investment ideas, which can make the difference in a tough market. Jefferies' research effort covers U.S. & International equity, high yield, convertibles, investment grade fixed income and post-reorganization securities, as well as special situations and quantitative research. The more than 120-person team of research professionals covers over 1,200 companies in more than 40 industries worldwide. Our analysts focus on identifying emerging industry themes and dig deeper to provide in-depth, thought provoking, objective research. Our analysts use a variety of quantitative and qualitative tools, integrating field analysis, proprietary channel checks and ongoing dialogue with the managements of the companies they cover. We utilize the latest technologies to deliver a research product that is timely, differentiated, and tailored to each customer's needs. Regular client access to companies and their management teams is provided through a wide variety of Jefferies hosted industry conferences, company management meetings and on-site tours.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/4/2009 8:25 AM Sell
12.10 5.00
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/16/2008 8:25 AM Hold
18.30 19.00
8/4/2008 8:25 AM Hold
24.60 25.00
4/1/2008 8:25 AM Buy
20.35 30.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy